First Time Loading...

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 109.29 USD -0.92% Market Closed
Updated: May 3, 2024

Jazz Pharmaceuticals PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jazz Pharmaceuticals PLC
Operating Income Peer Comparison

Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Operating Income
$659.4m
CAGR 3-Years
9%
CAGR 5-Years
0%
CAGR 10-Years
7%
Perrigo Company PLC
NYSE:PRGO
Operating Income
$284.1m
CAGR 3-Years
1%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Operating Income
-$137.8m
CAGR 3-Years
-51%
CAGR 5-Years
-30%
CAGR 10-Years
-11%
G
GH Research PLC
NASDAQ:GHRS
Operating Income
-$41.2m
CAGR 3-Years
-351%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Operating Income
€12.2m
CAGR 3-Years
61%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Ovoca Bio PLC
LSE:OVB
Operating Income
-€2.3m
CAGR 3-Years
15%
CAGR 5-Years
-8%
CAGR 10-Years
12%

See Also

What is Jazz Pharmaceuticals PLC's Operating Income?
Operating Income
659.4m USD

Based on the financial report for Dec 31, 2023, Jazz Pharmaceuticals PLC's Operating Income amounts to 659.4m USD.

What is Jazz Pharmaceuticals PLC's Operating Income growth rate?
Operating Income CAGR 10Y
7%

Over the last year, the Operating Income growth was 505%. The average annual Operating Income growth rates for Jazz Pharmaceuticals PLC have been 9% over the past three years , and 7% over the past ten years .